The role of CD4 and CD8 T cells in human cutaneous leishmaniasis.

Frontiers in Public Health. 2014;2 DOI 10.3389/fpubh.2014.00165

 

Journal Homepage

Journal Title: Frontiers in Public Health

ISSN: 2296-2565 (Online)

Publisher: Frontiers Media S.A.

LCC Subject Category: Medicine: Public aspects of medicine

Country of publisher: Switzerland

Language of fulltext: English

Full-text formats available: PDF, HTML, ePUB, XML

 

AUTHORS

Claudia Ida Brodskyn (Centro de Pesquisa Gonçalo Moniz-FIOCRUZ/BA)
Claire da Silva Santos (Centro de Pesquisa Gonçalo Moniz-FIOCRUZ/BA)

EDITORIAL INFORMATION

Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 14 weeks

 

Abstract | Full Text

Leishmaniasis, caused by infection with parasites of the Leishmania genus, affects millions of individuals worldwide. This disease displays distinct clinical manifestations ranging from self-healing skin lesions to severe tissue damage. The control of Leishmania infection is dependent on cellular immune mechanisms, and evidence has shown that CD4 and CD8 T lymphocytes play different roles in the outcome of leishmaniasis. Although the presence of CD4 T cells is important for controlling parasite growth, the results in the literature suggest that the inflammatory response elicited by these cells could contribute to the pathogenesis of lesions. However, recent studies on CD8 T lymphocytes show that these cells are mainly involved in tissue damage through cytotoxic mechanisms. In this review, we focus on the recent advances in the study of the human adaptive immunological response in the pathogenesis of tegumentary leishmaniasis.